JEREMY HEINERICH: Open Payments
NPI 1952457772 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,037 in 23 payments from 7 companies in 2025. Trend: 2023 $305 · 2024 $323 · 2025 $2,037
Travel & lodging: $1,221Food & beverage: $815
| Company | Payments | Amount |
|---|---|---|
| Adaptive Biotechnologies Corporation | 11 | $1,283 |
| Becton, Dickinson and Company | 2 | $304 |
| Bard Peripheral Vascular, Inc. | 3 | $145 |
| Kite Pharma, Inc. | 1 | $139 |
| Janssen Biotech, Inc. | 4 | $113 |
| Legend Biotech USA Inc. | 1 | $27 |
| Rigel Pharmaceuticals, Inc. | 1 | $26 |
Products named: clonoSEQ, Trek, Yescarta, CARVYKTI, TECVAYLI, TAVALISSE.
Industry payments across NY — which companies pay providers there.
